Cargando...
Treatment of Myelofibrosis: Old and New Strategies
Myelofibrosis (MF) is a BCR-ABL1–negative myeloproliferative neoplasm that is mainly characterised by reactive bone marrow fibrosis, extramedullary haematopoiesis, anaemia, hepatosplenomegaly, constitutional symptoms, leukaemic progression, and shortened survival. As such, this malignancy is still o...
Guardado en:
| Publicado en: | Clin Med Insights Blood Disord |
|---|---|
| Autores principales: | , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
SAGE Publications
2017
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5428134/ https://ncbi.nlm.nih.gov/pubmed/28579852 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1179545X17695233 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|